首页> 外文期刊>Life sciences >Tumor control by hypoxia-specific chemotargeting of iron-oxide nanoparticle – Berberine complexes in a mouse model
【24h】

Tumor control by hypoxia-specific chemotargeting of iron-oxide nanoparticle – Berberine complexes in a mouse model

机译:小鼠模型中氧化铁纳米粒子缺氧纳米粒子的缺氧特异性化学性化肿瘤控制

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Aim To evaluate the therapeutic efficacy of hypoxic cell-sensitizer Sanazole (SAN) –directed targeting of cytotoxic drug Berberine (BBN) and Iron-oxide nanoparticle (NP) complexes, to solid tumor in Swiss albino mice. Main methods NP-BBN-SAN complexes were characterized by FTIR, XRD, TEM and Nano-size analyzer. This complex was orally administered to mice-bearing solid tumor in hind limb. Tumor regression was analysed by measuring tumor volume. Cellular DNA damages were assessed by comet assay. Transcriptional expression of genes related to tumor hypoxia and apoptosis was evaluated by quantitative real-time PCR and morphological changes in tissues were analysed by histopathology. Also levels of antioxidants and tumor markers in tissues and serum biochemical parameters were analysed. Key findings Administration of NP-BBN-SAN complexes reduced tumor volume and studies were focussed on the underlying mechanisms. Extensive damage to cellular-DNA; down-regulated transcription of hif-1α, vegf, akt and bcl2 ; and up-regulated expression of bax and caspases, were observed in tumor. Results on tumor markers, antioxidant-status and serum parameters corroborated the molecular findings. Histopathology of tumor, liver and kidney revealed the therapeutic specificity of NP-BBN-SAN. Significance Thus SAN and NP can be used for specific targeting of drugs, to hypoxic solid tumor, to improve therapeutic efficacy. Graphical abstract The administration of NP-BBN-SAN complexes is found to down regulate the expression of genes responsible for hypoxia-induced tumor progression. Further the complexes initiates the up regulation of apoptotic genes' expression. It causes apoptosis in tumor, which is further evidenced from histopathology, and leads to tumor regression. SAN has the capability to accumulate in hypoxic area of tumor, hence it directs the cytotoxic drug BBN in the complexes to tumor to facilitate tumor regression. Histopathology of Liver and Kidney of these animals are appeared normal which is a major evidence for treatment specificity. NP- Iron-oxide nanoparticles, BBN- Berberine, SAN- Sanazole, hif-1alpha: hypoxia inducible factor-1 alpha, vegf: vascular endothelial growth factor, akt . protein kinase B, bcl2: B-cell lymphoma 2, bax: bcl2-associated X protein, GPx: glutathione peroxidase, GSH: glutathione, SOD- superoxidde dismutase, MDA- malodialdehyde. Display Omitted
机译:摘要旨在评价缺氧细胞 - 敏化剂Sanazole(San) - 分枝氧化物(BBN)和氧化铁纳米粒子(NP)复合物的靶向靶向的治疗疗效,在瑞士白化小鼠中的实体瘤中。主要方法是NP-BBN-SAN复合物的特点是FTIR,XRD,TEM和纳米尺寸分析仪。将该复合物口服给予后肢的小鼠实体肿瘤。通过测量肿瘤体积分析肿瘤回归。通过彗星测定评估细胞DNA损伤。通过定量实时PCR评估与肿瘤缺氧和凋亡相关的基因的转录表达,并通过组织病理学分析组织的形态学变化。分析了组织中的抗氧化剂和肿瘤标志物的水平和血清生物化学参数。关键发现施用NP-BBN-SAN复合物降低的肿瘤体积和研究侧重于潜在机制。对细胞DNA的广泛损害; HIF-1α,VEGF,AKT和BCL2的下调转录;在肿瘤中观察到肿瘤和木糖的上调表达。结果肿瘤标志物,抗氧化状态和血清参数证实了分子结果。肿瘤,肝肾组织病理学揭示了NP-BBN-SAN的治疗特异性。因此,SAN和NP可用于药物的特定靶向,以改善治疗效果的特定靶向。图解摘要发现NP-BBN-SAN复合物的给药下来调节负责缺氧诱导的肿瘤进展的基因的表达。此外,复合物引发了凋亡基因的表达的调控。它导致肿瘤细胞凋亡,这进一步从组织病理学中证明,并导致肿瘤回归。 SAN具有积聚在肿瘤的缺氧区域中的能力,因此它将络合物中的细胞毒性药物BBN引导至肿瘤,以促进肿瘤回归。这些动物的肝脏和肾脏的组织病理学是正常的,这是治疗特异性的主要证据。 NP-氧化铁纳米粒子,BBN-小檗碱,San-Sanazole,HIF-1α:缺氧诱导因子-1α,VEGF:血管内皮生长因子,AKT。蛋白质激酶B,BCL2:B细胞淋巴瘤2,BAX:BCL2相关X蛋白,GPX:谷胱甘肽过氧化物酶,GSH:谷胱甘肽,SOD-超氧化酵母歧化酶,MDA-羟基醛。显示省略

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号